Absci (ABSI) Total Liabilities (2020 - 2026)
Absci's (ABSI) quarterly Total Liabilities came in at $23.6 million in Q1 2026, down 29.8% year-on-year from $33.7 million in Q1 2025, and down 12.02% quarter-over-quarter from $26.8 million in Q4 2025.
Absci (ABSI) Total Liabilities (2020 - 2026) Analysis & Trends
Absci has disclosed Total Liabilities across 7 years of filings, most recently posting $23.6 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $23.6 million, down 29.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.6 million (down 29.8% YoY), and the FY2025 annual result was $26.8 million, down 22.12% from the prior year.
- Total Liabilities came in at $23.6 million for Q1 2026 at Absci, down from $26.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $55.0 million in Q1 2022 to a low of $23.6 million in Q1 2026.
- The 5-year median for Total Liabilities is $36.5 million (2025), against an average of $38.4 million.
- Across the five-year window, Total Liabilities slumped 77.21% in 2022 and rose 7.28% in 2025, its largest moves.
- Absci's Total Liabilities stood at $46.6 million in 2022, then declined by 11.74% to $41.1 million in 2023, then decreased by 16.16% to $34.5 million in 2024, then fell by 22.12% to $26.8 million in 2025, then slipped by 12.02% to $23.6 million in 2026.
- The last three Total Liabilities figures came in at $23.6 million (Q1 2026), $26.8 million (Q4 2025), and $34.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 23.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.62 Mn |
| Dec 31, 2025 | 26.85 Mn |
| Sep 30, 2025 | 34.65 Mn |
| Jun 30, 2025 | 36.52 Mn |
| Mar 31, 2025 | 33.65 Mn |
| Dec 31, 2024 | 34.48 Mn |
| Sep 30, 2024 | 33.90 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 34.79 Mn |
| Dec 31, 2023 | 41.12 Mn |
| Sep 30, 2023 | 39.93 Mn |
| Jun 30, 2023 | 38.75 Mn |
| Mar 31, 2023 | 41.84 Mn |
| Dec 31, 2022 | 46.59 Mn |
| Sep 30, 2022 | 46.45 Mn |
| Jun 30, 2022 | 50.12 Mn |
| Mar 31, 2022 | 54.96 Mn |
| Dec 31, 2021 | 60.09 Mn |
| Sep 30, 2021 | 61.11 Mn |
| Jun 30, 2021 | 219.96 Mn |